Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer

NCT00334802 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: gemcitabine
DRUG: paclitaxel

Sponsor

Eli Lilly and Company